CbdMD Correlations
| YCBD Stock | USD 0.40 0.03 6.98% |
The current 90-days correlation between cbdMD Inc and CV Sciences is -0.05 (i.e., Good diversification). The correlation of CbdMD is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
CbdMD Correlation With Market
Significant diversification
The correlation between cbdMD Inc and DJI is 0.02 (i.e., Significant diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding cbdMD Inc and DJI in the same portfolio, assuming nothing else is changed.
CbdMD |
Moving together with CbdMD Stock
| 0.61 | A | Agilent Technologies | PairCorr |
| 0.72 | CUE | Cue Biopharma | PairCorr |
| 0.67 | TMO | Thermo Fisher Scientific | PairCorr |
| 0.67 | WAT | Waters | PairCorr |
| 0.69 | LTRN | Lantern Pharma | PairCorr |
| 0.65 | NTRA | Natera Inc | PairCorr |
Moving against CbdMD Stock
| 0.61 | INZY | Inozyme Pharma | PairCorr |
| 0.44 | NTLA | Intellia Therapeutics | PairCorr |
| 0.37 | NVO | Novo Nordisk AS | PairCorr |
| 0.34 | NAMSW | NewAmsterdam Pharma | PairCorr |
| 0.51 | CRNX | Crinetics Pharmaceuticals | PairCorr |
| 0.49 | TERN | Terns Pharmaceuticals | PairCorr |
| 0.43 | BNTC | Benitec Biopharma | PairCorr |
| 0.43 | CTMX | CytomX Therapeutics | PairCorr |
| 0.38 | ADTX | Aditxt Inc | PairCorr |
| 0.37 | REGN | Regeneron Pharmaceuticals | PairCorr |
| 0.36 | CRBU | Caribou Biosciences | PairCorr |
| 0.32 | ABOS | Acumen Pharmaceuticals | PairCorr |
Related Correlations Analysis
| Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between CbdMD Stock performing well and CbdMD Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze CbdMD's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| CVSI | 6.05 | 0.52 | 0.02 | 0.12 | 8.43 | 33.33 | 58.33 | |||
| CCHWF | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| TCNNF | 2.76 | (0.57) | 0.00 | 0.94 | 0.00 | 7.22 | 21.79 | |||
| CURLF | 3.31 | (0.60) | 0.00 | 2.19 | 0.00 | 10.22 | 22.86 | |||
| GTBIF | 1.85 | (0.48) | 0.00 | (0.90) | 0.00 | 3.45 | 10.49 | |||
| CPHI | 5.48 | 0.43 | 0.05 | (0.38) | 5.99 | 15.00 | 45.32 | |||
| HCANF | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| ALIM | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| SXTC | 19.97 | 9.65 | 1.69 | 1.37 | 3.56 | 15.91 | 40.37 |
CbdMD Corporate Management
| Zeb Booker | Chief Officer | Profile | |
| Raymond Coffman | CoFounder Chairman | Profile | |
| Kevin MacDermott | President | Profile | |
| John Weston | Director Relations | Profile | |
| Shannon Charles | Chief Officer | Profile | |
| Francisco Mangual | Senior Sales | Profile |